Julian A. Hiscox is Chair in Infection and Global Health and Deputy Associate Pro-Vice Chancellor for Research and Impact in the Faculty of Health and Life Sciences. He has a BSc in Genetics from University College London (1991) and a PhD in Virology from the University of Reading (1994). Julian completed post-doctoral training at the University of Alabama at Birmingham (USA) and the Institute for Animal Health (Compton, UK). In 1999 he was appointed as a Lecturer in Virology at the University of Reading and then moved to the University of Leeds in 2003 where he was subsequently a Senior Lecturer and Reader in Virology. In 2012 he was recruited to the University of Liverpool. His research group, composed of six PDRAs and ten PhD students, focuses on viral respiratory infections such as SARS-CoV-2, MERS-CoV, seasonal human coronaviruses and respiratory syncytial virus and emerging threats including Ebola virus. The group is also interested in biological and chemical threat agents. During the COVID-19 pandemic Julian was a co-opted member of the The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). This group advises the government on the threat posed by new and emerging respiratory viruses and he was a participant at SAGE. He is currently a member of NERVTAG until 2026. Julian is Director of the BBSRC/DEFRA funded UK-International coronavirus network.